Verified Nov 2026
Batteries & E-Mobility
·

Chiyoda, Tokyo
·
Since 1907
Kyowa Kirin International plc, headquartered in Tokyo and founded in 1907, is a specialty pharmaceutical company with 500-1,000 employees and estimated revenue of $1–5 billion. Operating through its North America division, it develops and commercializes therapies in oncology, immunology, nephrology, and neurology, with branded medicines including Crysvita and Poteligeo. The company recently announced plans for a research hub to strengthen drug discovery capabilities.
Kyowa Kirin International plc. at a glance
Revenue
$1-5B
Est. band
Employees
500-1,000
Founded
1907
Headquarters
Chiyoda, Tokyo
Industries
Automotive
Electric Vehicles
Medical
Overview
Kyowa Kirin International plc, headquartered in Tokyo and founded in 1907, is a specialty pharmaceutical company with 500-1,000 employees and estimated revenue of $1–5 billion. Operating through its North America division, it develops and commercializes therapies in oncology, immunology, nephrology, and neurology, with branded medicines including Crysvita and Poteligeo. The company recently announced plans for a research hub to strengthen drug discovery capabilities.
At a glance
Attribute | Detail |
|---|---|
Founded | 1907 |
Headquarters | Chiyoda, Tokyo |
Employees | 500-1,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
What Kyowa Kirin International plc. makes
The company provides integrated drug discovery, development, and commercialization services across oncology, immunology, nephrology, and neurology, supported by research facilities in La Jolla, California, and offices in Princeton, New Jersey and Toronto, Canada.
Latest developments
2026-08-31 — Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans | Kyowa Kirin North America (kyowakirin.com)
2026-06-30 — FDA Selects Kyowa Kirin for Precheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience | Kyowa Kirin North America (kyowakirin.com)
2026-05-07 — Kyowa Kirin Plans the Creation of State-of-the-Art Research Hub to Further Strengthen Drug Discovery Capabilities - Kyowa Kirin (kyowakirin.com)
2026-01-21 — Kyowa Kirin is Planting Deep Roots in Sanford | Sanford Area Growth Alliance (growsanfordnc.com)
2025-10-31 — Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases (pharmafocuseurope.com)
2025-04-11 — Kyowa Kirin Completed Construction of a New Biopharmaceutical DS Manufacturing Facility at Takasaki Plant - Kyowa Kirin (kyowakirin.com)
Facilities
Kyowa Kirin International plc. is headquartered in Chiyoda, Tokyo. Public sources also reference these locations:
Sanford, North Carolina — kyowakirin.com
Sanford, NC — linkedin.com
Japan — kyowakirin.com
Company details
Kyowa Kirin is a privately held subsidiary of a Japanese parent company serving rare disease and serious medical condition patient populations through branded therapeutics and patient support programs. Kyowa Kirin International plc. was founded in 1907, has an estimated 500-1,000 employees, and is headquartered in Chiyoda, Tokyo.
Frequently asked questions
What does Kyowa Kirin International plc. make?
Kyowa Kirin International plc, headquartered in Tokyo and founded in 1907, is a specialty pharmaceutical company with 500-1,000 employees and estimated revenue of $1–5 billion. Operating through its North America division, it develops and commercializes therapies in oncology, immunology, nephrology, and neurology, with branded medicines including Crysvita and Poteligeo. The company recently announced plans for a research hub to strengthen drug discovery capabilities.
Where is Kyowa Kirin International plc. headquartered?
Kyowa Kirin International plc. is headquartered in Chiyoda, Tokyo.
When was Kyowa Kirin International plc. founded?
Kyowa Kirin International plc. was founded in 1907.
How big is Kyowa Kirin International plc.?
Kyowa Kirin International plc. has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
